Related Experiment Video
Updated: Aug 13, 2026

Preparation of N-(2-alkoxyvinyl)sulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
Published on: January 3, 2018
Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates
J I Levin1, J M Chen, L M Laakso
1Wyeth Research, 401 N. Middletown Road, Pearl River, NY 10965, USA. levinji@wyeth.com
Researchers developed novel thiomorpholine sulfonamide hydroxamate TACE inhibitors. Compound 5h demonstrated potent activity and was selected as a clinical candidate for treating rheumatoid arthritis (RA).
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Immunology
Background:
- Tumor necrosis factor-alpha-converting enzyme (TACE) plays a crucial role in inflammatory diseases like rheumatoid arthritis (RA).
- Developing potent and orally active TACE inhibitors is a key therapeutic strategy for RA management.
Purpose of the Study:
- To synthesize and evaluate a novel series of thiomorpholine sulfonamide hydroxamate TACE inhibitors.
- To identify a clinical candidate with excellent in vitro and in vivo efficacy for RA treatment.
Main Methods:
- Synthesis of thiomorpholine sulfonamide hydroxamate derivatives with propargylic ether P1' groups.
- In vitro enzymatic and cellular assays to determine TACE inhibitory potency.
- In vivo studies using TNF-alpha production and collagen-induced arthritis models to assess oral activity.
Main Results:
- The synthesized compounds exhibited varying degrees of TACE inhibition.
- Compound 5h demonstrated excellent in vitro potency against isolated TACE and in cellular assays.
- Compound 5h showed significant oral activity in both TNF-alpha production and collagen-induced arthritis models.
Conclusions:
- Compound 5h, a thiomorpholine sulfonamide hydroxamate TACE inhibitor, possesses promising therapeutic potential for rheumatoid arthritis.
- The favorable in vitro and in vivo profile of compound 5h supports its advancement as a clinical candidate for RA treatment.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Anthelminthic Agents
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
